Last checked at 23 Jan 2015 14:31

23 January 2015
Avacta Group plc
("Avacta", the "Group" or the "Company")
Â
Â
Result of Annual General Meeting
Â
Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
Â
Following the Annual General Meeting, Gwyn Humphreys stood down from the Board with immediate effect. The Board would like to thank Gwyn for the service and support he has given to the Company and acknowledges the contribution he has made to the Group's progress.
Â
Â
Â
Avacta Group plc | www.avacta.com | |
Alastair Smith, Chief Executive Officer | Tel: +44 (0) 844 414 0452 | |
Tim Sykes, Chief Financial Officer | ||
 Numis Securities Limited |  Tel: +44 (0) 20 7260 1000 | |
Michael Meade / Freddie Barnfield (Nominated Adviser) | ||
James Black (Corporate Broking) | ||
 Walbrook PR Limited |  Tel: +44 (0) 20 7933 8780 or avacta@walbrookpr.com | |
Mike Wort | Mob: +44 (0)7900 608 002 | |
Anna Dunphy | Mob: +44 (0)7876 741 001 | |
Â
Â
About Avacta
Â
Avacta Group plc is a global provider of research reagents, consumables and equipment to the life sciences and animal care. Avacta operates through three divisions:
Â
Avacta Life Sciences www.avactalifesciences.com  | Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development. |
Avacta Animal Health www.avactaanimalhealth.com  | Veterinary diagnostics reference laboratory services, SensiTest, and diagnostic kits, SensiPak. |
Avacta Analytical www.avactaanalytical.com  | High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development. |
Â
Avacta joined AIM in August 2006 and is based in Wetherby, England.
Â
Â